Prabhat Agrawal has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Prabhat Agrawal, a shareholder of Entero Healthcare Solutions, has submitted a disclosure to the stock exchange under Regulation 31(4) of the SEBI Takeover Regulations, 2011. This regulation pertains to continual disclosures that must be made by persons who have previously made disclosures under the Takeover Code and have further acquired or sold shares in the company. The specific details of the transaction — whether it was a purchase or sale, the number of shares involved, and the resulting change in shareholding percentage — are not disclosed in this filing. Without further information from the detailed disclosure, the exact nature and impact of the transaction cannot be determined.
Since the specifics of the transaction (buy/sell, quantity, percentage change) are not provided in the announcement, there is no immediate clear directional impact on the stock or shareholders. Investors should look for the detailed disclosure on the exchange website to understand whether this is a promoter activity, creeping acquisition, or routine compliance filing.